Relationship between Fibrosis and Ventricular Arrhythmias in Chagas Heart Disease Without Ventricular Dysfunction

被引:35
|
作者
Tassi, Eduardo Marinho [1 ]
Continentino, Marcelo Abramoff [2 ]
do Nascimento, Emilia Matos [1 ,3 ]
Pereira, Basilio de Braganca [1 ,3 ]
Pedrosa, Roberto Coury [1 ]
机构
[1] Univ Fed Rio de Janeiro, Inst Cardiol Edson Saad, BR-21941 Rio De Janeiro, Brazil
[2] Hosp Frei Galvao, Guaratingueta, SP, Brazil
[3] Inst Alberto Luiz Coimbra Posgrad & Pesquisa Engn, COPPE, Rio De Janeiro, RJ, Brazil
基金
巴西圣保罗研究基金会;
关键词
Arrhythmias; Cardiac; Myocardial Fibrosis; Chagas Heart Disease; Ventricular Dysfunction; MAGNETIC-RESONANCE; AGREEMENT; FAILURE; DEATH;
D O I
10.5935/abc.20140052
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Patients with Chagas disease and segmental wall motion abnormality (SWMA) have worse prognosis independent of left ventricular ejection fraction (LVEF). Cardiac magnetic resonance (CMR) is currently the best method to detect SWMA and to assess fibrosis. Objective: To quantify fibrosis by using late gadolinium enhancement CMR in patients with Chagas disease and preserved or minimally impaired ventricular function (> 45%), and to detect patterns of dependence between fibrosis, SWMA and LVEF in the presence of ventricular arrhythmia. Methods: Electrocardiogram, treadmill exercise test, Holter and CMR were carried out in 61 patients, who were divided into three groups as follows: (1) normal electrocardiogram and CMR without SWMA; (2) abnormal electrocardiogram and CMR without SWMA; (3) CMR with SWMA independently of electrocardiogram. Results: The number of patients with ventricular arrhythmia in relation to the total of patients, the percentage of fibrosis, and the LVEF were, respectively: Group 1, 4/26, 0.74% and 74.34%; Group 2, 4/16, 3.96% and 68.5%; and Group 3, 11/19, 14.07% and 55.59%. Ventricular arrhythmia was found in 31.1% of the patients. Those with and without ventricular arrhythmia had mean LVEF of 59.87% and 70.18%, respectively, and fibrosis percentage of 11.03% and 3.01%, respectively. Of the variables SWMA, groups, age, LVEF and fibrosis, only the latter was significant for the presence of ventricular arrhythmia, with a cutoff point of 11.78% for fibrosis mass (p < 0.001). Conclusion: Even in patients with Chagas disease and preserved or minimally impaired ventricular function, electrical instability can be present. Regarding the presence of ventricular arrhythmia, fibrosis is the most important variable, its amount being proportional to the complexity of the groups.
引用
收藏
页码:456 / 463
页数:8
相关论文
共 50 条
  • [41] Programmed ventricular stimulation in structural heart disease: Implications of patterns of ventricular arrhythmias induced to long-term outcomes
    Singh, Gurbhej
    Prasad, Srinivasa
    Namboodiri, Narayanan
    Thajudeen, Anees
    Nair, Krishna Kumar Mohanan
    Abhilash, S. P.
    Tharakan, Jaganmohan A.
    Kumar, V. K. Ajit
    INDIAN HEART JOURNAL, 2023, 75 (01) : 17 - 24
  • [42] ELECTROCARDIOGRAPHIC ABNORMALITIES AND LEFT-VENTRICULAR SYSTOLIC FUNCTION IN CHAGAS HEART-DISEASE
    CASADO, J
    DAVILA, DF
    DONIS, JH
    TORRES, A
    PAYARES, A
    COLMENARES, R
    GOTTBERG, CF
    INTERNATIONAL JOURNAL OF CARDIOLOGY, 1990, 27 (01) : 55 - 62
  • [43] Greyzone myocardial fibrosis and ventricular arrhythmias in patients with a left ventricular ejection fraction &gt; 35%
    Zegard, Abbasin
    Okafor, Osita
    de Bono, Joseph
    Kalla, Manish
    Lencioni, Mauro
    Marshall, Howard
    Hudsmith, Lucy
    Qiu, Tian
    Steeds, Richard
    Stegemann, Berthold
    Leyva, Francisco
    EUROPACE, 2022, 24 (01): : 31 - 39
  • [44] SALICYLATE REDUCES VENTRICULAR DYSFUNCTION AND ARRHYTHMIAS DURING REPERFUSION IN ISOLATED RAT HEARTS
    LIU, XK
    TOSAKI, A
    ENGELMAN, RM
    DAS, DK
    JOURNAL OF CARDIOVASCULAR PHARMACOLOGY, 1992, 19 (02) : 209 - 215
  • [45] Favorable Effects of the Optimized Drug Treatment of Heart Failure on Ventricular Arrhythmias
    Good God, Epotamenides Maria
    Moreira, Maria da Consolacao V.
    Pereira Barretto, Antonio Carlos
    ARQUIVOS BRASILEIROS DE CARDIOLOGIA, 2008, 91 (06) : 363 - 369
  • [46] Right ventricular dysfunction in rheumatic heart valve disease: A clinicopathological evaluation
    Pande, Shantanu
    Agarwal, Surendra K.
    Tewari, Prabhat
    Agrawal, Vinita
    Srivastav, Nilesh
    Tripathi, Shashank
    Soni, Neetu
    Kumar, Sunil
    NATIONAL MEDICAL JOURNAL OF INDIA, 2020, 33 (06) : 329 - 334
  • [47] Gender and myocardial fibrosis by CMR are independent predictors of myocardial dysfunction in patients with Chagas' heart disease
    Antonildes N Assunção
    Bernardo B Lopes
    Alejandra Villanueva
    Liliane Rocha
    Carolina S Reiser
    Eduardo B Falchetto
    Simone Cristina S Costa
    Barbara Ianni
    Fabio Fernandes
    Marly U Lopes
    Roberto Kalil
    Carlos E Rochitte
    Journal of Cardiovascular Magnetic Resonance, 17 (Suppl 1)
  • [48] Strain echocardiography is related to fibrosis and ventricular arrhythmias in hypertrophic cardiomyopathy
    Haland, Trine F.
    Almaas, Vibeke M.
    Hasselberg, Nina E.
    Saberniak, Jorg
    Leren, Ida S.
    Hopp, Einar
    Edvardsen, Thor
    Haugaa, Kristina H.
    EUROPEAN HEART JOURNAL-CARDIOVASCULAR IMAGING, 2016, 17 (06) : 613 - 621
  • [49] Brain-heart interactions and cardiac ventricular arrhythmias
    Taggart, P.
    NETHERLANDS HEART JOURNAL, 2013, 21 (02) : 78 - 81
  • [50] Temporal Relationship of Conduction System Disease and Ventricular Dysfunction in LMNA Cardiomyopathy
    Brodt, Chad
    Siegfried, Jill D.
    Hofmeyer, Mark
    Martel, Jose
    Rampersaud, Evadnie
    Li, Duanxiang
    Morales, Ana
    Hershberger, Ray E.
    JOURNAL OF CARDIAC FAILURE, 2013, 19 (04) : 233 - 239